Pragmatic randomised trial of risperidone long acting injection versus oral atypical antipsychotics in poorly adherent subjects with schizophrenia in a routine care setting.

Trial Profile

Pragmatic randomised trial of risperidone long acting injection versus oral atypical antipsychotics in poorly adherent subjects with schizophrenia in a routine care setting.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2017

At a glance

  • Drugs Risperidone (Primary) ; Amisulpride; Antipsychotics; Aripiprazole; Olanzapine; Quetiapine
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms PRAGMATIC
  • Sponsors Janssen Inc
  • Most Recent Events

    • 07 Jul 2009 Actual number of patients (169) added as reported by ClinicalTrials.gov.
    • 07 Jul 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Jun 2009 Planned end date added as 1 Apr 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top